 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that SRDX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Surmodics (SRDX, $33.78) RSI Indicator left the oversold zone on September 18, 2023

This price move could indicate a change in the trend, and may be a sell signal for investors...

Surmodics (SRDX, $33.78) price exceeded its 50-day Moving Average on September 18, 2023

This price move could be a signal that SRDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Surmodics (SRDX, $35.53) price may climb as it broke lower Bollinger Band on Sep 12, 2023

This is a signal that SRDX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Surmodics (SRDX, $38.36) Stochastic Oscillator left the overbought zone on September 08, 2023

This is a Bearish indicator signaling SRDX's price could decline from here. Traders may explore shorting the stock or put options...

Surmodics (SRDX, $37.02) Moving Average Convergence Divergence (MACD) Histogram turned negative on August 24, 2023

NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is...

Sidoti Events, LLCs Virtual August Micro-Cap Conference

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences: The Needham Virtual MedTech & Diagnostics 1x1 Conference...

Surmodics to Participate in Upcoming Investor Conferences in August

This price move could be a signal that SRDX may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Surmodics (SRDX, $33.94) price may drop as it broke higher Bollinger Band on Aug 04, 2023

This is a signal that SRDX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Surmodics (SRDX, $33.94) RSI Indicator left the overbought zone on August 04, 2023

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023. Third...

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Watchers	174
52-Wk Low	$16.00
52-Wk High	$39.41

Market Cap	$441.12M
Volume (M)	31,562.00
52-Wk High	$39.41
52-Wk Low	$16.00

SRDX Surmodics, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals